Cochlear Aktie

Cochlear EBITDA-margin

EBITDA-margin for Cochlear (COH.AX) pr. 8. aug. 2026 er 22,32 %. I foregående år var EBITDA-margin 22,79 % — en ændring på -2,10 % (lavere).

EBITDA-margin

22,32 %

YoY

-2,10%

Senest opdateret:

EBITDA-margin for Cochlear er 2026 22,32 % . EBITDA-margin for Cochlear var 2025 22,79 % . Det falder dermed med -2,10% lavere sammenlignet med året før.
Access this data via the Eulerpool API

Cochlear Aktieanalyse

Hvad laver Cochlear? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Cochlear aktie

EBITDA-margin for Cochlear er 22,32 % i 2026.

EBITDA-margin for Cochlear ændrede sig fra 22,79 % til 22,32 %, hvilket repræsenterer en ændring på -2,10 %. Værdien er lavere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af EBITDA-margin Cochlear siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

EBITDA-marginen viser, hvilken procentdel af omsætningen der konverteres til EBITDA. Den normaliserer for af- og nedskrivninger og kapitalstrukturforskelle.

En 'god' varierer efter branche og virksomhedens udviklingsstadium. På Eulerpool kan du sammenligne EBITDA-margins Cochlear med konkurrenter og branchegjennemsnittet for at afgøre, om den er attraktiv.

For at evaluere EBITDA-margins er det afgørende at sammenligne det med andre virksomheder i samme branche og sektor. På Eulerpool kan du finde branchsammenligninger for EBITDA-margin.

Access this data via the Eulerpool API

Marginer — Cochlear

Alle nøgletal — Cochlear